1. Home
  2. TYG vs ARDX Comparison

TYG vs ARDX Comparison

Compare TYG & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tortoise Energy Infrastructure Corporation

TYG

Tortoise Energy Infrastructure Corporation

HOLD

Current Price

$40.02

Market Cap

891.7M

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.44

Market Cap

975.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYG
ARDX
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
891.7M
975.9M
IPO Year
2003
2014

Fundamental Metrics

Financial Performance
Metric
TYG
ARDX
Price
$40.02
$3.44
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $15.14
AVG Volume (30 Days)
127.6K
★ 3.9M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
★ 11.71%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
N/A
$34.24
P/E Ratio
$52.62
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$39.92
$3.33
52 Week High
$51.18
$8.40

Technical Indicators

Market Signals
Indicator
TYG
ARDX
Relative Strength Index (RSI) 28.55 33.22
Support Level N/A $3.33
Resistance Level $44.39 $3.92
Average True Range (ATR) 0.82 0.13
MACD -0.34 0.03
Stochastic Oscillator 4.37 18.80

Price Performance

Historical Comparison
TYG
ARDX

About TYG Tortoise Energy Infrastructure Corporation

Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: